ARPC2 expression might act as a promising prognostic marker in multiple cancers, especially for ACC, HNSC, KIRC, KIRP, LIHC(HCC), LGG, MESO, PAAD, UCEC, and UVM. This evidence concerns the gene ARPC2 and pancreatic adenocarcinoma.